Andover, MANCT07676084Now EnrollingIRB Ready

Dry Eye Disease (DED) Clinical Trial in Andover, MA

Access cutting-edge dry eye disease (ded) treatment through this phase 4 clinical trial at a research site in Andover. Study-provided care at no cost to qualified participants.

Sponsored by Andover Research Eye Institute

Quick Self-Assessment

See if you qualify for this Andover location

Preparing your pre-screening questions…

Expert Care in Andover

Access dry eye disease (ded) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related dry eye disease (ded) treatment provided free

Apply for This Andover Location

Check if you qualify for this dry eye disease (ded) clinical trial in Andover, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Andover

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Andover site if eligible
  4. 4Begin participation

About This Dry Eye Disease (DED) Study in Andover

A study to evaluate the effect of over- the- counter (OTC) lubricating eye drops on tolerability, symptoms and visual outcomes in patients with dry eye disease (DED)

Sponsor: Andover Research Eye Institute

Who Can Participate

Inclusion Criteria

Be at least 18 years of age, male or female
Able to provide written voluntary informed consent
Able and willing to adhere to the protocol instructions, including participation in all study visits
Subject-reported symptoms or history consistent with dry eye for at least 6 months prior to Screening/Baseline (Visit 1)
Ocular Surface Disease Index (OSDI) score \>13

Exclusion Criteria

Note: All ocular exclusion criteria apply to either eye.
DED secondary to destruction of conjunctival goblet cells due to ocular trauma (eg, alkali burns) or ocular or systemic condition (eg, Stevens-Johnson syndrome, ocular cicatricial pemphigoid, Vitamin A deficiency)
Any abnormal lid or corneal anatomy that would interfere with eyelid closure or create an irregular ocular tear film
Any active ocular infection, inflammation, or ocular allergy
Have undergone ocular surgery or laser refractive surgery within 9 months prior to Screening/Baseline (Visit 1)
Use of LipiFlow® procedure, intense pulse light procedure, or any kind of other procedure affecting meibomian glands within 6 months prior to Screening/Baseline (Visit 1)
Occlusion of the ocular puncta within 30 days prior to Screening/Baseline (Visit 1)
Have worn contact lenses within 3 days prior to Screening/Baseline (Visit 1) or planned wear during the study
Use of topical prescription products for dry eye, including topical ocular anti inflammatories (eg, cyclosporine, lifitegrast), corticosteroids, MIEBO® (perfluorohexyloctane ophthalmic solution), or TRYPTYR® (alcotremon ophthalmic solution) within 30 days prior to Screening/ Baseline (Visit 1)
Use of any eye drops (prescription or OTC, such as artificial tears or Lumify®) and/or TrueTear™ device (intranasal tear neurostimulator) within 24 hours prior to Screening/ Baseline (Visit 1)
Changes in any systemic medications known to impact tear production (eg, antihistamines, antidepressants, hormone replacement therapy, etc.) within 3 months prior to Screening/Baseline (Visit 1)
Have a serious or uncontrolled systemic disease (eg, diabetes, rheumatoid arthritis, lupus, hypertension, malignancy) that, in the opinion of the Investigator, will interfere with the study or interpretation of study results

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Andover?

Yes, this clinical trial (NCT07676084) has an active research site in Andover, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Dry Eye Disease (DED) Treatment Options in Andover, MA

If you're searching for dry eye disease (ded) treatment options in Andover, MA, this clinical trial (NCT07676084) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Andover research site is actively enrolling participants for this phase 4 clinical trial. You'll receive care from experienced dry eye disease (ded) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all dry eye disease (ded) clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Andover, MA

See all ankylosing spondylitis clinical trials recruiting in Andover — not just this study.

Browse Ankylosing Spondylitis Trials in Andover →

Ready to Join in Andover?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Andover, MA